Benjamin F Cravatt

94PUBLICATIONS
372CO-AUTHORS
ChemotherapyNeurology and neuromuscular diseasesMedical infection agents (incl. prions)Cheminformatics and quantitative structure-activity relationshipsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (94)

|Aug 28, 2026
An enantioselective covalent inhibitor of BAX confers cytoprotection in vivo.

|Jun 19, 2026
A fatty acid amide activates myeloid cells and improves neurovascular outcomes in retinal degeneration.

|Jun 15, 2026
Genetic and pharmacological inactivation of peptidoglycan remodeling increases antibiotic susceptibility of vancomycin-resistant Enterococcus faecium.

|May 20, 2026
A Global Ligandability Map of Tryptoline Butynamide Stereoprobes Identifies Covalent Inhibitors of the Actin Maturation Protease.

|Mar 27, 2026
Genetic and pharmacological inactivation of peptidoglycan remodeling increases antibiotic susceptibility of vancomycin-resistant Enterococcus faecium.

Kyong T Fam, Pavan Kumar Chodisetti, Zifei Wang

|Mar 11, 2026
Dissecting FOXA1 pioneering function by acute pharmacological degradation.

Lauren M Hargis, Paige A Barta, Yuxiang Zhang

Pageof 16

Frequent Collaborators

20 joint publications

Bruno Melillo

9 joint publications

Daisuke Ogasawara

8 joint publications

Xiaoyu Zhang

7 joint publications

Michael A Schafroth